Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Life Science Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The life science market size has expanded considerably in recent years. It is anticipated to grow from $109.53 billion in 2025 to $123.41 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.7%. The market’s past growth can be attributed to several factors, including increased investments in pharmaceutical R&D, the expansion of biotechnology companies, the adoption of laboratory automation, a growing demand for diagnostics, and the rising prevalence of chronic and rare diseases.
The life science market is anticipated to experience substantial expansion over the coming years. Its size is projected to reach $200.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This projected increase during the forecast period stems from several factors, including developments in precision medicine, the rise of digital health solutions, the incorporation of AI and big data analytics into research, greater cooperation between academic and commercial research entities, and the broadening of global clinical trials. Key developments expected during this period encompass advanced drug discovery platforms, integrated clinical trial management, high-throughput laboratory automation, regulatory compliance and consulting services, as well as bioinformatics and data analytics.
Download A Free Sample Report For Comprehensive Market Insights:
#Life Science Market Demand Drivers Creating New Revenue Opportunities
The anticipated expansion of the life science market is linked to the rising incidence of chronic diseases. These are defined as enduring ailments that generally advance gradually, necessitating continuous care instead of brief interventions. The rise in chronic diseases is attributed to detrimental lifestyle choices, including inadequate nutrition, lack of exercise, and escalating obesity figures. Life science plays a crucial role in tackling chronic diseases through facilitating the development of innovative treatments, diagnostic tools, and biological products, which enhance sustained disease control and patient well-being. A notable example is data from April 2025 by the Centers for Disease Control and Prevention, a US based government agency, indicating that in 2023, 76.4% (representing 194 million) of US adults disclosed having 1 or more chronic conditions. This figure included 59.5% of young adults, 78.4% of midlife adults, and 93.0% of older adults, respectively. Consequently, the growing frequency of chronic illnesses is a key factor boosting the expansion of the life science market.
Life Science Market Segment Landscape: Which Areas Lead Market Development?
The life science market covered in this report is segmented –
1) By Type: Biotechnology, Pharmaceuticals, Medical Devices, Life Science Tools, Digital Health Solutions
2) By Therapeutic Areas: Oncology, Cardiology, Neurology, Immunology, Rare Diseases, Other Therapeutic Areas
3) By Applications: Drug Discovery And Development, Diagnostics, Therapeutics, Clinical Trials, Research And Development
4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions, Hospitals And Clinics
Subsegments:
1) By Biotechnology: Genetic Engineering, Cell Based Technologies, Microbial Biotechnology, Industrial Biotechnology, Agricultural Biotechnology
2) By Pharmaceuticals: Prescription Drugs, Over The Counter Drugs, Generic Drugs, Branded Drugs, Specialty Drugs
3) By Medical Devices: Diagnostic Devices, Therapeutic Devices, Surgical Instruments, Monitoring Devices, Implantable Devices
4) By Life Science Tools: Laboratory Instruments, Reagents And Consumables, Analytical Tools, Sample Preparation Tools, Research Software Solutions
5) By Digital Health Solutions: Health Information Systems, Remote Patient Monitoring, Mobile Health Applications, Clinical Decision Support Systems, Healthcare Data Analytics
Life Science Market Trends Driving Strategic Industry Expansion
Key players in the life science market are concentrating on developing innovative products, such as patented peptide-based functional ingredients, to offer scientifically validated support for glucose regulation and metabolic well-being. These peptide-based functional ingredients are biologically active, short-chain amino acid compounds engineered to interact with specific metabolic pathways to provide targeted health advantages. For example, in December 2025, Greenyn Biotechnology Co. Ltd., a Taiwan-based company specializing in proprietary biotechnology-driven functional ingredients and health supplement solutions, introduced Insumate mcIRBP-19 Bitter Melon Peptide. This bioactive peptide is designed to support metabolic health in dietary supplement applications. The product features a unique bitter melon-derived peptide that mimics insulin receptor binding activity, thereby assisting blood glucose control. It is manufactured using a low-temperature supercritical extraction process to maintain the peptide’s bioactivity and consistency. Insumate mcIRBP-19 benefits from clinical validation and international certifications, establishing it as a next-generation, evidence-based nutraceutical ingredient targeting the rapidly expanding segment of metabolic health and diabetes support.
Life Science Market Industry Leaders And Market Competition
Major companies operating in the life science market are Johnson & Johnson, Roche Holding AG, Pfizer Inc., AbbVie Inc., AstraZeneca plc, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., Abbott Laboratories, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Eli Lily and Company, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck KGaA, Boehringer Ingelheim International GmbH, Vertex Pharmaceuticals Incorporated, Astellas Pharma Inc., Biogen Inc., bioMérieux SA, Sartorius AG
Access The Complete Life Science Market Report:
Life Science Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the life science market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.